Zoetis (ZTS) |
United States |
$76.784B |
41.85 |
Takeda Pharmaceutical (TAK) |
Japan |
$54.984B |
10.26 |
Astellas Pharma (ALPMY) |
Japan |
$29.565B |
18.47 |
Eisai (ESALY) |
Japan |
$22.210B |
19.35 |
Catalent (CTLT) |
United States |
$19.023B |
56.90 |
Grifols, S.A (GRFS) |
Spain |
$13.118B |
15.02 |
Neurocrine Biosciences (NBIX) |
United States |
$10.061B |
79.18 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$9.344B |
15.10 |
Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$8.578B |
0.00 |
Ionis Pharmaceuticals (IONS) |
United States |
$8.568B |
83.95 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$8.297B |
0.00 |
United Therapeutics (UTHR) |
United States |
$7.680B |
16.35 |
IPSEN SA ADR (IPSEY) |
France |
$7.218B |
0.00 |
Orion OYJ (ORINY) |
Finland |
$6.427B |
22.30 |
Evotec AG (EVTCY) |
Germany |
$5.819B |
394.44 |
Sage Therapeutics (SAGE) |
United States |
$4.756B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$4.673B |
0.00 |
Hypermarcas (HYPMY) |
Brazil |
$4.415B |
16.21 |
ChemoCentryx (CCXI) |
United States |
$4.292B |
0.00 |
FibroGen (FGEN) |
United States |
$3.934B |
0.00 |
Cronos Group (CRON) |
Canada |
$3.889B |
0.00 |
Corcept Therapeutics (CORT) |
United States |
$3.269B |
31.62 |
Pacira BioSciences (PCRX) |
United States |
$3.201B |
69.51 |
Nektar Therapeutics (NKTR) |
United States |
$3.046B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$2.972B |
15.17 |
Xencor (XNCR) |
United States |
$2.784B |
0.00 |
Revolution Medicines (RVMD) |
United States |
$2.706B |
0.00 |
Tilray (TLRY) |
Canada |
$2.630B |
0.00 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$1.766B |
15.11 |
Translate Bio (TBIO) |
United States |
$1.734B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.685B |
0.00 |
USANA Health Sciences (USNA) |
United States |
$1.669B |
14.69 |
Endo (ENDP) |
Ireland |
$1.640B |
2.49 |
Heron Therapeutics (HRTX) |
United States |
$1.603B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$1.542B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$1.470B |
0.00 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$1.448B |
10.06 |
ImmunoGen (IMGN) |
United States |
$1.404B |
0.00 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.151B |
0.00 |
Indivior (INVVY) |
United States |
$1.139B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$1.100B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.038B |
0.00 |
ORGANOGENESIS (ORGO) |
United States |
$1.024B |
0.00 |
Radius Health (RDUS) |
United States |
$1.012B |
0.00 |
CLINIGEN GP (CLIGF) |
United Kingdom |
$0.942B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$0.938B |
0.00 |
Vectura Group (VEGPF) |
United Kingdom |
$0.925B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.832B |
49.10 |
VAXART, INC (VXRT) |
United States |
$0.786B |
0.00 |
Calliditas Therapeutics AB (CALT) |
Sweden |
$0.721B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$0.712B |
0.00 |
Acutus Medical (AFIB) |
United States |
$0.659B |
0.00 |
Aerie Pharmaceuticals (AERI) |
United States |
$0.653B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.644B |
0.00 |
Chinook Therapeutics (KDNY) |
United States |
$0.641B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.635B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.615B |
0.00 |
Harpoon Therapeutics (HARP) |
United States |
$0.594B |
0.00 |
Siga Technologies (SIGA) |
United States |
$0.563B |
15.80 |
Molecular Templates (MTEM) |
United States |
$0.552B |
0.00 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$0.524B |
0.00 |
Sundial Growers (SNDL) |
Canada |
$0.504B |
0.00 |
PROFOUND MEDICL (PROF) |
Canada |
$0.491B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.468B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.441B |
0.00 |
Summit Therapeutics (SMMT) |
United States |
$0.438B |
0.00 |
Altimmune (ALT) |
United States |
$0.428B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.420B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$0.414B |
0.00 |
DURECT (DRRX) |
United States |
$0.412B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.400B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.389B |
0.00 |
Innate Pharma SA (IPHYF) |
France |
$0.371B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.363B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.363B |
0.00 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.362B |
9.43 |
MEI Pharma (MEIP) |
United States |
$0.320B |
0.00 |
Alpine Immune Sciences (ALPN) |
United States |
$0.313B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.312B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.304B |
19.59 |
Menlo Therapeutics (VYNE) |
United States |
$0.280B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.279B |
7.36 |
Redhill Biopharma (RDHL) |
Israel |
$0.278B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.266B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.263B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.252B |
0.00 |
Otonomy (OTIC) |
United States |
$0.251B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.245B |
0.00 |
IMV INC (IMV) |
Canada |
$0.237B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.235B |
0.00 |
OptiNose (OPTN) |
United States |
$0.218B |
0.00 |
Oncternal Therapeutics (ONCT) |
United States |
$0.213B |
0.00 |
Oasmia Pharmaceutical AB (OASMY) |
Sweden |
$0.209B |
0.00 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.204B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.188B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.186B |
0.00 |
Novan (NOVN) |
United States |
$0.180B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.179B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.172B |
0.00 |
Taiwan Liposome (TLC) |
Taiwan |
$0.166B |
0.00 |
ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.166B |
0.00 |
Ayala Pharmaceuticals (AYLA) |
Israel |
$0.165B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.150B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.146B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.146B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.145B |
0.00 |
MediWound (MDWD) |
Israel |
$0.137B |
0.00 |
Aptorum Group (APM) |
Hong Kong, SAR China |
$0.113B |
0.00 |
Lipocine (LPCN) |
United States |
$0.106B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.099B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.094B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.086B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.082B |
158.75 |
ElectroCore (ECOR) |
United States |
$0.080B |
0.00 |
Nutriband (NTRB) |
United States |
$0.077B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.076B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.070B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.070B |
0.00 |
Biomerica (BMRA) |
United States |
$0.067B |
0.00 |
ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.063B |
0.00 |
CV Sciences (CVSI) |
United States |
$0.063B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.059B |
0.00 |
Vical (BBI) |
United States |
$0.059B |
0.00 |
Addex Therapeutics (ADXN) |
Switzerland |
$0.059B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.054B |
0.00 |
RENEURON GP (RNUGF) |
United Kingdom |
$0.053B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.049B |
24.96 |
Regulus Therapeutics (RGLS) |
United States |
$0.047B |
0.00 |
PolarityTE (PTE) |
United States |
$0.042B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.038B |
0.00 |
Mannatechorporated (MTEX) |
United States |
$0.038B |
5.56 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.037B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.029B |
0.00 |
Midatech Pharma (MTP) |
United Kingdom |
$0.029B |
0.00 |
KemPharm (KMPH) |
United States |
$0.026B |
0.00 |
Flex Pharma (SLRX) |
United States |
$0.024B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.020B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.019B |
31.90 |
HANCOCK JAFFE (HJLI) |
United States |
$0.019B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.018B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.017B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.017B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.017B |
0.00 |
Cytori Therapeutics Inc (PSTV) |
United States |
$0.011B |
0.00 |
Shineco (TYHT) |
China |
$0.011B |
0.00 |
JanOne (JAN) |
United States |
$0.010B |
0.00 |
CannTrust Holdings (CTST) |
Canada |
$0.000B |
0.00 |